Smart-money series

SUPN Trades by Members of Congress

Stock trades disclosed by members of Congress on periodic transaction reports (PTRs), newest trade date first. Click a name for the member’s full record, or a filing for the original PTR. House filings are current. Our Senate source stopped on Nov 30, 2020, so recent Senate trades are missing.

House PTR filings as of Oct 20, 2026

Senate PTR filings as of Nov 30, 2020 · not updated for 2152 days; newer filings may exist

Company data, filings and insider activity for SUPN: SUPN stock page.

Latest disclosed trades

1–9 of 9
DateMemberAssetTypeAmountFiling
2026-03-03Gil Cisneros · D-CA-31SUPN · Supernus Pharmaceuticals, Inc. - Common StockBuy$1k – $15kPTR
2025-12-11Gil Cisneros · D-CA-31SUPN · Supernus Pharmaceuticals, Inc. - Common StockBuy$1k – $15kPTR
2025-10-09Gil Cisneros · D-CA-31SUPN · Supernus Pharmaceuticals, Inc. - Common StockPartial sell$1k – $15kPTR
2025-03-24Gil Cisneros · D-CA-31SUPN · Supernus Pharmaceuticals, Inc. - Common StockBuy$1k – $15kPTR
2022-12-23Josh Gottheimer · D-NJ-05SUPN · Supernus Pharmaceuticals, Inc.Partial sell$1k – $15kPTR
2020-11-13Gil Cisneros · D-CA-31SUPN · Supernus Pharmaceuticals, Inc.Buy$1k – $15k—
2020-07-17Gil Cisneros · D-CA-31SUPN · Supernus Pharmaceuticals, Inc.Buy$1k – $15k—
2020-06-01Gil Cisneros · D-CA-31SUPN · Supernus Pharmaceuticals, Inc.Buy$1k – $15k—
2020-05-28Josh Gottheimer · D-NJ-05SUPN · Supernus Pharmaceuticals, Inc.Buy$1k – $15k—

Where do these trades come from?

Members of Congress report stock trades on periodic transaction reports under the STOCK Act: within 30 days of being notified of a trade and no later than 45 days after it. Each report gives a trade date, the asset, buy or sell, and an amount band rather than an exact amount. This feed lists trades by trade date, so a trade reported today can appear below newer ones. See which members reported late on the STOCK Act late-filing tracker, the stocks the most members bought, or browse members of the House and Senate.

Source: U.S. House Clerk and Senate periodic transaction reports. Educational only — not investment advice. See our methodology.